Join experts Joshua Zeidner, MD from UNC Lineberger and Eunice Wang, MD from Roswell Park as they dive into the latest breakthroughs in menin inhibitors for acute myeloid leukemia (AML). They unravel how these inhibitors work against specific genetic mutations, offering hope in treating AML. The conversation covers exciting new data presented at the iwAL 2024, challenges in developing resistance, and the innovative combinations being explored to enhance efficacy. Get ready to learn about the future of targeted treatments in AML!